{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:27:57Z","timestamp":1793399277124,"version":"4.5.0"},"reference-count":68,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2015.0092","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:24:09Z","timestamp":1525253049000},"source":"Crossref","is-referenced-by-count":25,"title":["Uveitis in Juvenile Idiopathic Arthritis"],"prefix":"10.3238","author":[{"given":"Arnd","family":"Heiligenhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"F\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2015,2,6]]},"reference":[{"key":"10.3238\/arztebl.2015.0092_ref1","doi-asserted-by":"crossref","unstructured":"Paivonsalo-Hietanen T, Tuominen J, Saari KM: Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 2000; 78: 84\u20138.","DOI":"10.1034\/j.1600-0420.2000.078001084.x"},{"key":"10.3238\/arztebl.2015.0092_ref2","doi-asserted-by":"crossref","unstructured":"Edelsten C, Reddy A, Stanford MR, Graham EM: Visual loss associated with paediatric uveitis in english primary and referral centers. Am J Ophthalmol 2003; 135: 676\u201380.","DOI":"10.1016\/S0002-9394(02)02148-7"},{"key":"10.3238\/arztebl.2015.0092_ref3","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K: Review of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 2013; 21: 180\u201391.","DOI":"10.3109\/09273948.2013.791701"},{"key":"10.3238\/arztebl.2015.0092_ref4","unstructured":"Petty RE, Southwood TR, Manners P: International league of associations for rheumatology. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390\u20132."},{"key":"10.3238\/arztebl.2015.0092_ref5","doi-asserted-by":"crossref","unstructured":"Carvounis PE, Herman DC, Cha S, Burke JP: Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefe\u00b4s Arch Clin Exp Ophthalmol 2006; 244: 281\u201390.","DOI":"10.1007\/s00417-005-0087-3"},{"key":"10.3238\/arztebl.2015.0092_ref6","doi-asserted-by":"crossref","unstructured":"Angeles-Han ST, Griffin KW, Harrison MJ, et al.: Development of a vision-related quality of life instrument for children ages 8\u201318 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res 2011; 63: 1254\u201361.","DOI":"10.1002\/acr.20524"},{"key":"10.3238\/arztebl.2015.0092_ref7","unstructured":"Minden K, Niewerth M, Listing J, et al.: The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database. Clin Exp Rheumatol 2009; 27: 863\u20139."},{"key":"10.3238\/arztebl.2015.0092_ref8","unstructured":"Berntson L, Andersson Gare B, Fasth A, et al.: Nordic Study Group Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003; 30: 2275\u201382."},{"key":"10.3238\/arztebl.2015.0092_ref9","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K: Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 2007; 46: 1015\u20139.","DOI":"10.1093\/rheumatology\/kem053"},{"key":"10.3238\/arztebl.2015.0092_ref10","doi-asserted-by":"crossref","unstructured":"Kotaniemi K, Kautiainen H, Karma A, Aho K: Occurrence of uveitis in recently diagnosed juvenile chronic arthritis. A prospective study. Ophthalmology 2001; 108: 2071\u20135.","DOI":"10.1016\/S0161-6420(01)00773-4"},{"key":"10.3238\/arztebl.2015.0092_ref11","doi-asserted-by":"crossref","unstructured":"Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM: An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 2002; 86: 51\u20136.","DOI":"10.1136\/bjo.86.1.51"},{"key":"10.3238\/arztebl.2015.0092_ref12","doi-asserted-by":"crossref","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, et al.: Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005; 140: 509\u201316.","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"10.3238\/arztebl.2015.0092_ref13","doi-asserted-by":"crossref","unstructured":"Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA: Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 2007; 143: 840\u20136.","DOI":"10.1016\/j.ajo.2007.01.033"},{"key":"10.3238\/arztebl.2015.0092_ref14","doi-asserted-by":"crossref","unstructured":"Sijssens KM, Rothova A, Berendschot TTJM, de Boer JH: Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology 2006; 113: 853\u20139.","DOI":"10.1016\/j.ophtha.2006.01.043"},{"key":"10.3238\/arztebl.2015.0092_ref15","doi-asserted-by":"crossref","unstructured":"Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A: Prevalence of uveitic glaucoma and success of non-surgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm 2009; 17: 443\u20138.","DOI":"10.1080\/09273940902913035"},{"key":"10.3238\/arztebl.2015.0092_ref16","doi-asserted-by":"crossref","unstructured":"De Boer J, Steljaert A, van den Bor R, Stellato R, Ossewarde-van Norel J: Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopahic arthritis. Ocul Immunol Inflamm 2014; (Epub ahead of print).","DOI":"10.3109\/09273948.2013.871566"},{"key":"10.3238\/arztebl.2015.0092_ref17","doi-asserted-by":"crossref","unstructured":"Kanski JJ: Anterior uveitis in juvenile rheumatoid arthritis. Arch Ophthalmol 1977; 95: 1794\u20137.","DOI":"10.1001\/archopht.1977.04450100096010"},{"key":"10.3238\/arztebl.2015.0092_ref18","unstructured":"Bolt JB, Cannizzaro E, Seger R, Saurenmann RK: Risk factors and long-term outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol 2008; 35: 703\u20136."},{"key":"10.3238\/arztebl.2015.0092_ref19","doi-asserted-by":"crossref","unstructured":"Gregory II AC, Kempen JH, Daniel E, et al.: Risk factors for loss of visual acuity among patients wit uveitis associated with juvenile idiopathic arthritis: The SITE study. Ophthalmology 2013; 120: 186\u201392.","DOI":"10.1016\/j.ophtha.2012.07.052"},{"key":"10.3238\/arztebl.2015.0092_ref20","doi-asserted-by":"crossref","unstructured":"De Boer J, Wulffraat N, Rothova A: Visual loss in uveitis of childhood. Br J Ophthalmol 2003; 87: 879\u201384.","DOI":"10.1136\/bjo.87.7.879"},{"key":"10.3238\/arztebl.2015.0092_ref21","doi-asserted-by":"crossref","unstructured":"Chia A, Lee V, Graham EM, Edelsten C: Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol 2003; 35: 757\u201362.","DOI":"10.1016\/S0002-9394(03)00225-3"},{"key":"10.3238\/arztebl.2015.0092_ref22","doi-asserted-by":"crossref","unstructured":"Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP: Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis (JIA). Am J Ophthalmol 2007; 143: 647\u201355.","DOI":"10.1016\/j.ajo.2006.11.025"},{"key":"10.3238\/arztebl.2015.0092_ref23","doi-asserted-by":"crossref","unstructured":"Braakenburg AM, de Valk HW, de Boer J, Rothova A: Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol 2008; 145: 472\u20139.","DOI":"10.1016\/j.ajo.2007.11.009"},{"key":"10.3238\/arztebl.2015.0092_ref24","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Michels H, Schumacher C, et al.: Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int 2012; 32: 1121\u201333.","DOI":"10.1007\/s00296-011-2126-1"},{"key":"10.3238\/arztebl.2015.0092_ref25","doi-asserted-by":"crossref","unstructured":"Lovell DJ, Ruperto N, Goodman S, et al.: Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008; 359: 810\u201320.","DOI":"10.1056\/NEJMoa0706290"},{"key":"10.3238\/arztebl.2015.0092_ref26","doi-asserted-by":"crossref","unstructured":"Zannin ME, Birolo C, Gerloni V, et al.: Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. J Rheumatol 2013; 40: 74\u20139.","DOI":"10.3899\/jrheum.120583"},{"key":"10.3238\/arztebl.2015.0092_ref27","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K: Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology 2011; 50: 1390\u20134.","DOI":"10.1093\/rheumatology\/ker107"},{"key":"10.3238\/arztebl.2015.0092_ref28","doi-asserted-by":"crossref","unstructured":"Tappeiner C, Heinz C, Ganser G, Heiligenhaus A: Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? J Rheumatol 2012; 39: 1294\u20135.","DOI":"10.3899\/jrheum.120010"},{"key":"10.3238\/arztebl.2015.0092_ref29","doi-asserted-by":"crossref","unstructured":"Zulian F, Balzarin M, Falcini F, et al.: Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis. Arthritis Care Res 2010; 62: 821\u20135.","DOI":"10.1002\/acr.20115"},{"key":"10.3238\/arztebl.2015.0092_ref30","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Foeldvari I, Edelsten C, et al.: Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res 2012; 64: 1365\u201372.","DOI":"10.1002\/acr.21674"},{"key":"10.3238\/arztebl.2015.0092_ref31","doi-asserted-by":"crossref","unstructured":"Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH: Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol 2011; 151: 217\u201322.","DOI":"10.1016\/j.ajo.2010.08.021"},{"key":"10.3238\/arztebl.2015.0092_ref32","doi-asserted-by":"crossref","unstructured":"Foell D, Wulffraat N, Wedderburn LR, et al.: Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission a randomized clinical trial. JAMA 2010; 303: 1266\u201373.","DOI":"10.1001\/jama.2010.375"},{"key":"10.3238\/arztebl.2015.0092_ref33","doi-asserted-by":"crossref","unstructured":"Kotaniemi K, Penttila H: Intraocular lens implantation in patients with juvenile idiopathic arthritis-associated uveitis. Ophthalmic Res 2006; 38: 318\u201323.","DOI":"10.1159\/000096225"},{"key":"10.3238\/arztebl.2015.0092_ref34","doi-asserted-by":"crossref","unstructured":"Sijssens KM, Los LI, Rothova A, et al.: Long-term ocular complications in aphakic versus pseudophakic eyes of children with juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol 2010; 94: 1145\u20139.","DOI":"10.1136\/bjo.2009.167379"},{"key":"10.3238\/arztebl.2015.0092_ref35","doi-asserted-by":"crossref","unstructured":"H\u00e4berle H, Velhagen KH, Pleyer U: Pseudophakie bei Kindern mit juveniler Arthritis. Ophthalmologe. 1998; 95: 823\u20137.","DOI":"10.1007\/s003470050360"},{"key":"10.3238\/arztebl.2015.0092_ref36","doi-asserted-by":"crossref","unstructured":"Foster CS, Havrlikova K, Baltatzis S, Christen WG, Merayo-Lloves J: Secondary glaucoma in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol Scand 2000; 78: 576\u20139.","DOI":"10.1034\/j.1600-0420.2000.078005576.x"},{"key":"10.3238\/arztebl.2015.0092_ref37","doi-asserted-by":"crossref","unstructured":"Papadopoulou C, Kostik M, B\u00f6hm M, et al.: Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. J Pediatr 2013; 163: 879\u201384.","DOI":"10.1016\/j.jpeds.2013.03.047"},{"key":"10.3238\/arztebl.2015.0092_ref38","unstructured":"Ravelli A: Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. Clin Exp Rheumatol 2004; 22: 271\u20135."},{"key":"10.3238\/arztebl.2015.0092_ref39","doi-asserted-by":"crossref","unstructured":"Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M: Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis 2005; 64: 871\u20134.","DOI":"10.1136\/ard.2004.026955"},{"key":"10.3238\/arztebl.2015.0092_ref40","doi-asserted-by":"crossref","unstructured":"Vidqvist KL, Malin M, Varjolahti-Lehtinen T, Korpela MM: Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatology 2013; 52: 1999\u20132003.","DOI":"10.1093\/rheumatology\/ket256"},{"key":"10.3238\/arztebl.2015.0092_ref41","unstructured":"Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A: A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol 1999; 17: 119\u201322."},{"key":"10.3238\/arztebl.2015.0092_ref42","doi-asserted-by":"crossref","unstructured":"Hudde T, Neudorf U, Heiligenhaus A, et al.: Diagnostik bei Uveitis im Kindesalter: Welche Tests bei welcher Uveitis? Klin Monatsbl Augenheilkd 2007; 224: 494\u20139.","DOI":"10.1055\/s-2007-963062"},{"key":"10.3238\/arztebl.2015.0092_ref43","doi-asserted-by":"crossref","unstructured":"Sch\u00fcler A, Coupland SE, Krause L, Bornfeld N: Maligne und nichtmaligne Uveitis-Maskierungssyndrome im Kindesalter. Klin Monatsbl Augenheilk 2007; 224: 477\u201382.","DOI":"10.1055\/s-2007-963274"},{"key":"10.3238\/arztebl.2015.0092_ref44","unstructured":"Dreesbach J, Zurek-Imhoff B, B\u00f6ttner K, Mussinghoff P, Heinz C, Heiligenhaus A: Krankheitskosten bei juveniler idiopathischer Arthritis-assoziierter Uveitis. Der Ophthalmologe 2013; 110; 29."},{"key":"10.3238\/arztebl.2015.0092_ref45","doi-asserted-by":"crossref","unstructured":"Modesto C, Ant\u00f3n J, Rodriguez B, et al.: Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol 2010; 39: 472\u20139.","DOI":"10.3109\/03009741003742722"},{"key":"10.3238\/arztebl.2015.0092_ref46","doi-asserted-by":"crossref","unstructured":"Watanabe Duffy KN, Lee J, Guzman J, et al.: The research in arthritis in Canadian children emphasizing outcomes (ReACCh Out) cohort. Prospective determination of the incidence of new onset uveitis in juvenile idiopathic arthritis. Arthritis Rheumatol 2014; 66 (Suppl 11): S21\u20132.","DOI":"10.1002\/art.38424"},{"key":"10.3238\/arztebl.2015.0092_ref47","doi-asserted-by":"crossref","unstructured":"Zeggini E, Packham J, Donn R, et al.: Association of HLA-DRB1*13 with susceptibility to uveitis in juvenile idiopathic arthritis in two independent data sets. Rheumatology 2006; 45: 972\u20139.","DOI":"10.1093\/rheumatology\/kel049"},{"key":"10.3238\/arztebl.2015.0092_ref48","doi-asserted-by":"crossref","unstructured":"Angeles-Han ST, McCracken C, Pichavant M, et al.: HLA associations in a matched cohort of juvenile idiopathic arthritis children with and without uveitis. Arthritis Rheumatol. 2014; 66: 160\u20131.","DOI":"10.1002\/art.38544"},{"key":"10.3238\/arztebl.2015.0092_ref49","doi-asserted-by":"crossref","unstructured":"Saurenmann RK, Rose JB, Tyrrell P, et al.: Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Ethnicity as a risk factor. Arthritis Rheum 2007; 56: 1974\u201384.","DOI":"10.1002\/art.22709"},{"key":"10.3238\/arztebl.2015.0092_ref50","unstructured":"Linssen A, Rothova A, Valkenburg HA, et al.: The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibilty antigen HLA-B27. Invest Ophthalmol Vis Sci 1991; 32: 2568\u201378."},{"key":"10.3238\/arztebl.2015.0092_ref51","doi-asserted-by":"crossref","unstructured":"Ducos de Lahitte G, Terrada C, et al.: Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study. Br J Ophthalmol 2008; 92: 64\u20139.","DOI":"10.1136\/bjo.2007.120675"},{"key":"10.3238\/arztebl.2015.0092_ref52","doi-asserted-by":"crossref","unstructured":"Wolf MD, Lichter PR, Ragsdale CG: Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 1987; 94: 1242\u20138.","DOI":"10.1016\/S0161-6420(87)80007-6"},{"key":"10.3238\/arztebl.2015.0092_ref53","unstructured":"Chalom EC, Goldsmith DP, Koehler MA: Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol 1997; 24: 2031\u20134."},{"key":"10.3238\/arztebl.2015.0092_ref54","doi-asserted-by":"crossref","unstructured":"Dana MR, Merayo-Lloves J, Schamberg DA, Foster CS: Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 1997; 104: 236\u201344.","DOI":"10.1016\/S0161-6420(97)30329-7"},{"key":"10.3238\/arztebl.2015.0092_ref55","unstructured":"Zulian F, Martini G, Falcini F, et al.: Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis. J Rheumatol 2002; 29: 2446\u201353."},{"key":"10.3238\/arztebl.2015.0092_ref56","doi-asserted-by":"crossref","unstructured":"Kalinina Ayuso V, Makhotkina N, van Tent-Hoeve M, et al.: Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown. Surv Ophthalmol 2014; 59: 517\u201331.","DOI":"10.1016\/j.survophthal.2014.03.002"},{"key":"10.3238\/arztebl.2015.0092_ref57","unstructured":"Foeldvari I, Wierk A: Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005; 32: 362\u20135."},{"key":"10.3238\/arztebl.2015.0092_ref58","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Mingels A, Heinz C, Ganser G: Methotrexate for uveitis associated with juvenile idiopahic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol 2007; 17: 743\u20138.","DOI":"10.1177\/112067210701700509"},{"key":"10.3238\/arztebl.2015.0092_ref59","doi-asserted-by":"crossref","unstructured":"Biester S, Deuter C, Michels H, et al.: Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 2007; 91: 319\u201324.","DOI":"10.1136\/bjo.2006.103721"},{"key":"10.3238\/arztebl.2015.0092_ref60","doi-asserted-by":"crossref","unstructured":"Simonini G, Taddio A, Cattalini M, et al.: Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab and infliximab. Arthritis Care Res 2011; 63: 612\u20138.","DOI":"10.1002\/acr.20404"},{"key":"10.3238\/arztebl.2015.0092_ref61","doi-asserted-by":"crossref","unstructured":"Smith JA, Thompson DJ, Whitcup SM, et al.: A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005; 53: 18\u201323.","DOI":"10.1002\/art.20904"},{"key":"10.3238\/arztebl.2015.0092_ref62","doi-asserted-by":"crossref","unstructured":"Tappeiner C, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A: Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye 2009; 23: 1192\u20138.","DOI":"10.1038\/eye.2008.174"},{"key":"10.3238\/arztebl.2015.0092_ref63","doi-asserted-by":"crossref","unstructured":"Bratton ML, He YG, Weakley DR: Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis. J AAPOS 2014; 18: 110\u20133.","DOI":"10.1016\/j.jaapos.2013.11.014"},{"key":"10.3238\/arztebl.2015.0092_ref64","doi-asserted-by":"crossref","unstructured":"Gerss J, Roth J, Holzinger D, et al.: Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis 2012; 71: 1991\u20137.","DOI":"10.1136\/annrheumdis-2012-201329"},{"key":"10.3238\/arztebl.2015.0092_ref65","doi-asserted-by":"crossref","unstructured":"Walscheid K, Holzinger D, Heinz C, et al.: S100 A8\/A9 serum levels are elevated in juvenile idiopathic arthritis-associated uveitis. Pediatric Rheumatol 2013; 11: 80.","DOI":"10.1186\/1546-0096-11-S2-P80"},{"key":"10.3238\/arztebl.2015.0092_ref66","doi-asserted-by":"crossref","unstructured":"Grajewski RS, Zurek-Imhoff B, Roesel M, Heinz C, Heiligenhaus A: Favorable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis. Acta Ophthalmol 2012; 90: 657\u201362.","DOI":"10.1111\/j.1755-3768.2011.02110.x"},{"key":"10.3238\/arztebl.2015.0092_ref67","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Bertram B, Heinz C, et al.: Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augen\u00e4rzte Deutschlands zur intravitrealen Therapie des Makula\u00f6dems bei Uveitis. Der Ophthalmologe 2014; 111: 740\u20138.","DOI":"10.1007\/s00347-014-3130-0"},{"key":"10.3238\/arztebl.2015.0092_ref68","unstructured":"Schenck S, Klotsche J, Niewerth M, et al.: Inzidenzanalyse der JIA \u2013 assoziierten Uveitis im zeitlichen Verlauf (2000\u20132012). Monatsschr Kinderheilkd 2014; 162: 252."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:19:40Z","timestamp":1638796780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,6]]},"references-count":68,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2015.0092","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,6]]}}}